Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2006 1
2007 3
2008 2
2011 1
2012 5
2013 4
2014 1
2015 3
2016 3
2017 4
2018 5
2019 4
2020 8
2021 5
2022 5
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
The C250T Mutation of TERTp Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T Mutation.
Gorria T, Crous C, Pineda E, Hernandez A, Domenech M, Sanz C, Jares P, Muñoz-Mármol AM, Arpí-Llucía O, Melendez B, Gut M, Esteve A, Esteve-Codina A, Parra G, Alameda F, Carrato C, Aldecoa I, Mallo M, de la Iglesia N, Balana C. Gorria T, et al. Among authors: carrato c. Cancers (Basel). 2024 Feb 9;16(4):735. doi: 10.3390/cancers16040735. Cancers (Basel). 2024. PMID: 38398126 Free PMC article.
New molecular tools for precision medicine in pituitary neuroendocrine tumors.
Marques-Pamies M, Gil J, Valassi E, Pons L, Carrato C, Jordà M, Puig-Domingo M. Marques-Pamies M, et al. Among authors: carrato c. Minerva Endocrinol (Torino). 2024 Jan 23. doi: 10.23736/S2724-6507.23.04063-0. Online ahead of print. Minerva Endocrinol (Torino). 2024. PMID: 38261299
Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly.
Marques-Pamies M, Gil J, Valassi E, Hernández M, Biagetti B, Giménez-Palop O, Martínez S, Carrato C, Pons L, Villar-Taibo R, Araujo-Castro M, Blanco C, Simón I, Simó-Servat A, Xifra G, Vázquez F, Pavón I, García-Centeno R, Zavala R, Hanzu FA, Mora M, Aulinas A, Vilarrasa N, Librizzi S, Calatayud M, de Miguel P, Alvarez-Escola C, Picó A, Sampedro M, Salinas I, Fajardo-Montañana C, Cámara R, Bernabéu I, Jordà M, Webb SM, Marazuela M, Puig-Domingo M. Marques-Pamies M, et al. Among authors: carrato c. Front Endocrinol (Lausanne). 2023 Oct 31;14:1269787. doi: 10.3389/fendo.2023.1269787. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38027102 Free PMC article.
Predictive signature of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer integrating mRNA expression, taxonomic subtypes, and clinicopathological features.
Font A, Domenech M, Ramirez JL, Marqués M, Benítez R, Ruiz de Porras V, Gago JL, Carrato C, Sant F, Lopez H, Castellano D, Malats N, Calle ML, Real FX. Font A, et al. Among authors: carrato c. Front Oncol. 2023 Aug 3;13:1155244. doi: 10.3389/fonc.2023.1155244. eCollection 2023. Front Oncol. 2023. PMID: 37588099 Free PMC article.
Molecular characterization of epithelial-mesenchymal transition and medical treatment related-genes in non-functioning pituitary neuroendocrine tumors.
Gil J, Marques-Pamies M, Valassi E, Serra G, Salinas I, Xifra G, Casano-Sancho P, Carrato C, Biagetti B, Sesmilo G, Marcos-Ruiz J, Rodriguez-Lloveras H, Rueda-Pujol A, Aulinas A, Blanco A, Hostalot C, Simó-Servat A, Muñoz F, Rico M, Ibáñez-Domínguez J, Cordero E, Webb SM, Jordà M, Puig-Domingo M. Gil J, et al. Among authors: carrato c. Front Endocrinol (Lausanne). 2023 Mar 22;14:1129213. doi: 10.3389/fendo.2023.1129213. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37033229 Free PMC article.
Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker.
Martínez-Bosch N, Vilariño N, Alameda F, Mojal S, Arumí-Uria M, Carrato C, Aldecoa I, Ribalta T, Vidal N, Bellosillo B, Menéndez S, Del Barco S, Gallego O, Pineda E, López-Martos R, Hernández A, Mesia C, Esteve-Codina A, de la Iglesia N, Balañá C, Martínez-García M, Navarro P. Martínez-Bosch N, et al. Among authors: carrato c. Cells. 2023 Mar 8;12(6):843. doi: 10.3390/cells12060843. Cells. 2023. PMID: 36980184 Free PMC article.
In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastoma.
Hernandez A, Muñoz-Mármol AM, Esteve-Codina A, Alameda F, Carrato C, Pineda E, Arpí-Lluciá O, Martinez-García M, Mallo M, Gut M, Del Barco S, Gallego O, Dabad M, Mesia C, Bellosillo B, Domenech M, Vidal N, Aldecoa I, de la Iglesia N, Balana C. Hernandez A, et al. Among authors: carrato c. Sci Rep. 2022 Aug 24;12(1):14439. doi: 10.1038/s41598-022-18608-8. Sci Rep. 2022. PMID: 36002559 Free PMC article.
Data mining analyses for precision medicine in acromegaly: a proof of concept.
Gil J, Marques-Pamies M, Sampedro M, Webb SM, Serra G, Salinas I, Blanco A, Valassi E, Carrato C, Picó A, García-Martínez A, Martel-Duguech L, Sardon T, Simó-Servat A, Biagetti B, Villabona C, Cámara R, Fajardo-Montañana C, Álvarez-Escolá C, Lamas C, Alvarez CV, Bernabéu I, Marazuela M, Jordà M, Puig-Domingo M. Gil J, et al. Among authors: carrato c. Sci Rep. 2022 May 28;12(1):8979. doi: 10.1038/s41598-022-12955-2. Sci Rep. 2022. PMID: 35643771 Free PMC article.
Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response.
Gil J, Marques-Pamies M, Valassi E, García-Martínez A, Serra G, Hostalot C, Fajardo-Montañana C, Carrato C, Bernabeu I, Marazuela M, Rodríguez-Lloveras H, Cámara R, Salinas I, Lamas C, Biagetti B, Simó-Servat A, Webb SM, Picó A, Jordà M, Puig-Domingo M. Gil J, et al. Among authors: carrato c. Biomedicines. 2022 Feb 16;10(2):460. doi: 10.3390/biomedicines10020460. Biomedicines. 2022. PMID: 35203668 Free PMC article.
54 results